Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Clubs
Explore
More
Language
English
English
TX
Tongji Xie
Cancer Immunotherapy and Biomarkers
Chinese Academy of Medical Sciences & Peking Union Medical College
Share
Follow
Claim This Profile
About
Research focus
Cancer Immunotherapy and Biomarkers
Impact
83 pubs · 504 cites · h-index 12
Affiliations
Chinese Academy of Medical Sciences & Peking Union Medical College
Nanjing Drum Tower Hospital
Peking Union Medical College Hospital
See all
Publications
Recent publications by Tongji Xie
Case report of neoadjuvant treatment with sugemalimab combined with platinum-based doublet chemotherapy in stage IIIB lung squamous cell carcinoma and research in potential biomarkers
Heliyon · Tue,
Mechanisms and therapeutic targets in distant metastasis of lung adenocarcinoma
Signal Transduction and Targeted Therapy · Thu,
Multiomic characterization of malignant pulmonary nodules and development of a methylation-based diagnostic Model
Journal of Translational Medicine · Mon,
Biomarker exploration for immunotherapy plus chemotherapy following resistance to third-generation EGFR-TKIs in lung adenocarcinoma
BMC Cancer · Tue,
Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancer
npj Precision Oncology · Fri,
Sustainable Bioremediation of Plastic Waste: How the Flame Retardant TCPP Affects Polyurethane Foam Biodegradation by Galleria mellonella Larvae
Sustainability · Fri,
Graphitized Biochar Derived from Agricultural Wastes Enhances Methanogenesis via Conductivity‐Driven Direct Interspecies Electron Transfer
Advanced Science · Mon,
A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma
Experimental Hematology and Oncology · Tue,
Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma
Hepatology Communications · Wed,
DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma
Cell Death and Disease · Thu,